TY - CHAP
T1 - Early (Uncomplicated) Parkinson's Disease
AU - Oertel, W. H.
AU - Berardelli, A.
AU - Bloem, B. R.
AU - Bonuccelli, U.
AU - Burn, D.
AU - Deuschl, G.
AU - Dietrichs, E.
AU - Fabbrini, G.
AU - Ferreira, J. J.
AU - Friedman, A.
AU - Kanovsky, P.
AU - Kostic, V.
AU - Nieuwboer, A.
AU - Odin, P.
AU - Poewe, W.
AU - Rascol, O.
AU - Sampaio, C.
AU - Schüpbach, M.
AU - Tolosa, E.
AU - Trenkwalder, C.
PY - 2010/9/6
Y1 - 2010/9/6
KW - Adjunctive therapy of parkinsonism
KW - Catechol-O-methyltransferase (COMT) inhibitors-reducing metabolism of levodopa, extending its plasma half-life
KW - Classification of scientific evidence and rating of recommendations-according to EFNS guidance
KW - Delayed-start results, compatible with concept-that 1 mg/day rasagiline is possibly efficacious for disease modification
KW - Early (uncomplicated) Parkinson's disease
KW - Levodopa, most effective therapy-for improving motor symptoms in Parkinson's disease (PD)
KW - Neurosurgical management of early stage PD
KW - Patients, with persistent or emerging disabling, tremor
KW - Symptomatic pharmacotherapy of parkinsonism
KW - Symptomatic treatment of parkinsonism (monotherapy)
UR - http://www.scopus.com/inward/record.url?scp=84855302877&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84855302877&partnerID=8YFLogxK
U2 - 10.1002/9781444328394.ch14
DO - 10.1002/9781444328394.ch14
M3 - Chapter
AN - SCOPUS:84855302877
SN - 9781405185332
VL - 1
SP - 217
EP - 236
BT - European Handbook of Neurological Management: Second Edition
PB - Wiley-Blackwell
ER -